Vaxart, Inc. Company Profile
Vaxart, Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, California, United States.
- Mailing address: Value 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, California, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, California, United States |
| Mailing address | 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, California, United States |
| Industry (SIC) | 2836 Biological Products, (No Diagnostic Substances) |
| Fiscal year end | 12-31 |
| Filer category | Accelerated filer<br>Smaller reporting company |
| Listed stock (Section 12(b)) | Common Stock, $0.0001 par value · VXRT 10-K/A filed 2026-04-30 cover |
| Shell company | No 10-K/A filed 2026-04-30 cover |
| Smaller reporting company | Yes 10-K/A filed 2026-04-30 cover |
| Emerging growth company | No 10-K/A filed 2026-04-30 cover |
| Well-known seasoned issuer | No 10-K/A filed 2026-04-30 cover |
| Voluntary filer | No 10-K/A filed 2026-04-30 cover |
| Current in its reporting | Yes 10-K/A filed 2026-04-30 cover |
| Former names | Aviragen Therapeutics, Inc. (2016-04-26 to 2018-02-15) Biota Pharmaceuticals, Inc. (2012-11-14 to 2016-04-13) NABI BIOPHARMACEUTICALS (2010-07-21 to 2012-11-08) NABI BIOPHARMACEUTICALS (2002-04-15 to 2010-06-29) NABI /DE/ (1996-11-27 to 2002-02-14) NORTH AMERICAN BIOLOGICALS INC (1994-11-08 to 1996-02-14) |
| First EDGAR filing | 1994-11-08 (SC 13G) |
| SEC CIK | 72444 |
| EIN | 591212264 |
| Phone | (650) 550-3500 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |